GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- B7442 W146Summary: sphingosine-1-phosphate receptor S1P1 antagonist
- B7463 RF 9Summary: neuropeptide FF receptors antagonist
- B7469 CorticosteroneSummary: Endogenous glucocorticoid
- B7515 1-Oleoyl lysophosphatidic acid sodium saltTarget: LPA ReceptorsSummary: Activates LPA receptor
- B7523 MRS 2768 tetrasodium saltSummary: P2Y2 agonist
- B7525 WAY 207024 dihydrochlorideSummary: GnRH-R antagonist, potent
- B7531 WAY 208466 dihydrochlorideTarget: 5-HT6 ReceptorSummary: 5-HT6 agonist
- B7538 WAY 267464 dihydrochlorideSummary: oxytocin receptor (OTR) agonist
- B7580 TCS 2510Summary: EP4 agonist
- B7581 PF9 tetrasodium saltSummary: GPR17 agonist